{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:18Z","timestamp":1792791558874,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111186","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:02:00Z","timestamp":1789023720000},"page":"111186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Alterations of telomere-associated genes and underlying mechanisms in hypoxic-ischemic encephalopathy"],"prefix":"10.1016","volume":"301","author":[{"given":"Huaqing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglian","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111186_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s43018-023-00519-w","article-title":"Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2","volume":"4","author":"Adler","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.neuropharm.2026.111186_bib2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12964-023-01048-w","article-title":"LOX-1 mediates inflammatory activation of microglial cells through the p38-MAPK\/NF-kappaB pathways under hypoxic-ischemic conditions","volume":"21","author":"Aoki","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.neuropharm.2026.111186_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156565","article-title":"Plasmatic profiles of cytokines\/chemokines, glial fibrillary acidic protein (GFAP) and MRI brain damage in neonates with hypoxic ischemic encephalopathy (HIE)","volume":"177","author":"Auriti","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.neuropharm.2026.111186_bib4","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12519-024-00836-9","article-title":"Neonatal encephalopathy due to suspected hypoxic ischemic encephalopathy: pathophysiology, current, and emerging treatments","volume":"20","author":"Babbo","year":"2024","journal-title":"World J Pediatr"},{"key":"10.1016\/j.neuropharm.2026.111186_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041701","article-title":"Telomere dynamics in human health and disease","volume":"17","author":"Baird","year":"2025","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2022.151639","article-title":"Neuroprotection for hypoxic-ischemic encephalopathy: contributions from the neonatal research network","volume":"46","author":"Bonifacio","year":"2022","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/imr.13050","article-title":"Imaging dendritic cell functions","volume":"306","author":"Bosnjak","year":"2022","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.neuropharm.2026.111186_bib8","first-page":"CD013202","article-title":"Stem cell-based interventions for the prevention of morbidity and mortality following hypoxic-ischaemic encephalopathy in newborn infants","volume":"8","author":"Bruschettini","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2026.111186_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1179\/016164101101199234","article-title":"Bromocriptine and the expression of c-myc and c-fos in human prolactinomas","volume":"23","author":"Burdman","year":"2001","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2026.111186_bib10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/dmcn.16184","article-title":"Neuroprotection for neonatal hypoxic-ischemic encephalopathy: a review of novel therapies evaluated in clinical studies","volume":"67","author":"Chan","year":"2025","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186567","article-title":"CCL4 inhibition in atherosclerosis: effects on plaque stability, endothelial cell adhesiveness, and macrophages activation","volume":"21","author":"Chang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111186_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.998","article-title":"ATF3 regulates SPHK1 in cardiomyocyte injury via endoplasmic reticulum stress","volume":"11","author":"Chen","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.neuropharm.2026.111186_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117307","article-title":"PFGA12 ameliorates Hypoxic-Ischemic brain injury by directly regulating PRDX1 and inhibiting ferroptosis","volume":"242","author":"Chen","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib14","article-title":"Inference of immune cell composition on the expression profiles of mouse tissue","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111186_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.neulet.2008.06.051","article-title":"Induction of suppressor of cytokine signaling-3 in astrocytes of the rat hippocampus following transient forebrain ischemia","volume":"441","author":"Choi","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2026.111186_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jconrel.2020.08.037","article-title":"Hydrogen sulfide-modified extracellular vesicles from mesenchymal stem cells for treatment of hypoxic-ischemic brain injury","volume":"328","author":"Chu","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.neuropharm.2026.111186_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/cells8010019","article-title":"Oxidative stress induces telomere dysfunction and senescence by replication fork arrest","volume":"8","author":"Coluzzi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neuropharm.2026.111186_bib18","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1007\/s00415-002-0903-1","article-title":"Levodopa and bromocriptine in hypoxic brain injury","volume":"249","author":"Debette","year":"2002","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cell.2013.09.048","article-title":"Super-resolution fluorescence imaging of telomeres reveals TRF2-dependent T-loop formation","volume":"155","author":"Doksani","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2026.111186_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.molcel.2019.04.024","article-title":"Targeted and persistent 8-Oxoguanine base damage at telomeres promotes telomere loss and crisis","volume":"75","author":"Fouquerel","year":"2019","journal-title":"Mol Cell"},{"key":"10.1016\/j.neuropharm.2026.111186_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103278","article-title":"Role of the telomeric factor TRF2 in post-hypoxic brain damages","volume":"75","author":"Gao","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13105-023-00989-7","article-title":"Silencing suppressor of cytokine signaling 3 induces apoptosis and activates the p-STAT3\/NF-kappaB pathway in hypoxic cultivated H9c2 cells","volume":"80","author":"Gu","year":"2024","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.neuropharm.2026.111186_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.586905","article-title":"Reducing suppressors of cytokine Signaling-3 (SOCS3) expression promotes M2 macrophage polarization and functional recovery after intracerebral hemorrhage","volume":"11","author":"Ji","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.70000","article-title":"Identification and analysis of oxidative stress-related genes in hypoxic-ischemic brain damage using bioinformatics and experimental verification","volume":"12","author":"Jin","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.neuropharm.2026.111186_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.633610","article-title":"The role of NF-kappaB triggered inflammation in cerebral ischemia","volume":"15","author":"Jover-Mengual","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111186_bib26","doi-asserted-by":"crossref","first-page":"13000","DOI":"10.1093\/nar\/gkab1142","article-title":"TIN2 is an architectural protein that facilitates TRF2-mediated trans- and cis-interactions on telomeric DNA","volume":"49","author":"Kaur","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2026.111186_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020792","article-title":"CXCL1: gene, promoter, regulation of expression, mRNA stability, regulation of activity in the intercellular space","volume":"23","author":"Korbecki","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111186_bib28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/pr.2017.266","article-title":"The effects of adding prophylactic phenobarbital to therapeutic hypothermia in the term-equivalent hypoxic-ischemic rat","volume":"83","author":"Krishna","year":"2018","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2026.111186_bib29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood.V76.6.1173.1173","article-title":"Thrombin induces c-fos expression in cultured human endothelial cells by a Ca2(+)-dependent mechanism","volume":"76","author":"Lampugnani","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.neuropharm.2026.111186_bib30","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00011-020-01402-5","article-title":"Quercetin alleviates neonatal hypoxic-ischemic brain injury by inhibiting microglia-derived oxidative stress and TLR4-mediated inflammation","volume":"69","author":"Le","year":"2020","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.neuropharm.2026.111186_bib31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000521540","article-title":"Progesterone as a neuroprotective agent in neonatal hypoxic-ischaemic encephalopathy: a systematic review","volume":"45","author":"Lee","year":"2023","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111186_bib32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12974-020-02057-z","article-title":"The immune response of T cells and therapeutic targets related to regulating the levels of T helper cells after ischaemic stroke","volume":"18","author":"Lei","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111186_bib33","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14220","article-title":"Telomerase reverse transcriptase promotes angiogenesis in neonatal rats after hypoxic-ischemic brain damage","volume":"10","author":"Li","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.neuropharm.2026.111186_bib34","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/01616412.2022.2056339","article-title":"Telomerase reverse transcriptase (TERT) promotes neurogenesis after hypoxic-ischemic brain damage in neonatal rats","volume":"44","author":"Li","year":"2022","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2026.111186_bib35","article-title":"Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10522-021-09910-5","article-title":"Aging and age-related diseases: from mechanisms to therapeutic strategies","volume":"22","author":"Li","year":"2021","journal-title":"Biogerontology"},{"key":"10.1016\/j.neuropharm.2026.111186_bib37","article-title":"Clinical seizures and unfavorable brain MRI patterns in neonates with hypoxic ischemic encephalopathy","volume":"100","author":"Lin","year":"2021","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.neuropharm.2026.111186_bib38","article-title":"Ursolic acid ameliorates cerebral ischemia-reperfusion injury by inhibiting NF-kappaB\/NLRP3-mediated microglia pyroptosis and neuroinflammation","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib39","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0006-8993(00)03124-3","article-title":"Effects of baclofen on colon inflammation-induced Fos, CGRP and SP expression in spinal cord and brainstem","volume":"889","author":"Lu","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111186_bib40","first-page":"556","article-title":"Long-term dosing of intrathecal baclofen in the treatment of spasticity after acquired brain injury","volume":"9","author":"Maneyapanda","year":"2017","journal-title":"Pharm. Manag. PM R"},{"key":"10.1016\/j.neuropharm.2026.111186_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/561494","article-title":"The role of cytokines and inflammatory cells in perinatal brain injury","volume":"2012","author":"McAdams","year":"2012","journal-title":"Neurol. Res. Int."},{"key":"10.1016\/j.neuropharm.2026.111186_bib42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MOP.0b013e328336eb57","article-title":"Erythropoietin for infants with hypoxic-ischemic encephalopathy","volume":"22","author":"McPherson","year":"2010","journal-title":"Curr. Opin. Pediatr."},{"key":"10.1016\/j.neuropharm.2026.111186_bib43","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1134\/S0006297925600814","article-title":"Telomere length and telomerase activity as biomarkers in the diagnostics and prognostics of pathological conditions","volume":"90","author":"Moskaleva","year":"2025","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.neuropharm.2026.111186_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gde.2020.02.007","article-title":"Genetic determinants of telomere length and cancer risk","volume":"60","author":"Nelson","year":"2020","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.neuropharm.2026.111186_bib45","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1111\/jcmm.16971","article-title":"Preclinical assessment of thrombin-preconditioned human Wharton's jelly-derived mesenchymal stem cells for neonatal hypoxic-ischaemic brain injury","volume":"25","author":"Noh","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.neuropharm.2026.111186_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/exnr.1999.7248","article-title":"Is Fos protein expressed by dying striatal neurons after immature hypoxic-ischemic brain injury?","volume":"161","author":"Oorschot","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib47","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/nar\/gki273","article-title":"Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2","volume":"33","author":"Opresko","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2026.111186_bib48","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041707","article-title":"Oxidative stress and DNA damage at telomeres","volume":"17","author":"Opresko","year":"2025","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib49","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/STROKEAHA.118.023837","article-title":"Location of neutrophils in different compartments of the damaged mouse brain after severe Ischemia\/Reperfusion","volume":"50","author":"Otxoa-de-Amezaga","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2026.111186_bib50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000533388","article-title":"Effect of Leuprolide Acetate, a GnRH agonist, on neuroinflammation and anxiety-like behavior after mild hypoxic-ischemic encephalopathy in Rat model","volume":"30","author":"Pedroza-Garcia","year":"2023","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.neuropharm.2026.111186_bib51","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12974-020-02037-3","article-title":"CCL3 contributes to secondary damage after spinal cord injury","volume":"17","author":"Pelisch","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2026.111186_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117682","article-title":"Network pharmacology combines machine learning, molecular simulation dynamics and experimental validation to explore the mechanism of acetylbinankadsurin A in the treatment of liver fibrosis","volume":"323","author":"Peng","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12206653","article-title":"Advances in therapies to treat neonatal hypoxic-ischemic encephalopathy","volume":"12","author":"Ranjan","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.neuropharm.2026.111186_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.540878","article-title":"Involvement of CXCL1\/CXCR2 during Microglia activation following inflammation-sensitized hypoxic-ischemic brain injury in neonatal rats","volume":"11","author":"Serdar","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1199233","article-title":"Reactive oxygen species formation and its effect on CD4(+) T cell-mediated inflammation","volume":"14","author":"Shu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0891-5849(03)00271-5","article-title":"Formation of hydrogen peroxide and nitric oxide in rat skeletal muscle cells during contractions","volume":"35","author":"Silveira","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neuropharm.2026.111186_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020590","article-title":"Molecular aspects of senescence and organismal Ageing-DNA damage response, telomeres, inflammation and chromatin","volume":"22","author":"Slawinska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111186_bib58","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1749-6632.1997.tb48634.x","article-title":"A model of perinatal hypoxic-ischemic brain damage","volume":"835","author":"Vannucci","year":"1997","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2026.111186_bib59","first-page":"196","article-title":"Comparative physiology of sound localization in four species of owls","volume":"36","author":"Volman","year":"1990","journal-title":"Brain Behav. Evol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib60","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0968-0004(02)02110-2","article-title":"Oxidative stress shortens telomeres","volume":"27","author":"von Zglinicki","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2026.111186_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-98504-z","article-title":"Combined treatment with mesenchymal stem cells and therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy: a phase 1\/2 randomized trial","volume":"15","author":"Wada","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.111186_bib62","article-title":"PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib63","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/JLB.3MR0621-616RR","article-title":"Role of IL-6 in dendritic cell functions","volume":"111","author":"Xu","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib64","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s12035-024-04398-9","article-title":"Hypoxic-Ischemic encephalopathy: pathogenesis and promising therapies","volume":"62","author":"Yang","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib65","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1177\/0271678X19891839","article-title":"Early neutrophil infiltration is critical for inflammation-sensitized hypoxic-ischemic brain injury in newborns","volume":"40","author":"Yao","year":"2020","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neuropharm.2026.111186_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115065","article-title":"Inhibition of PAD4-mediated neutrophil extracellular traps formation attenuates hypoxic-ischemic brain injury in neonatal mice","volume":"384","author":"Yu","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2026.111186_bib67","article-title":"Treating seizures after hypoxic-ischemic encephalopathy-current controversies and future directions","volume":"22","author":"Zhou","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:56:27Z","timestamp":1792788987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":67,"alternative-id":["S0028390826003618"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111186","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alterations of telomere-associated genes and underlying mechanisms in hypoxic-ischemic encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111186","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111186"}}